Latest Insider Transactions at Cargo Therapeutics, Inc. (CRGX)
This section provides a real-time view of insider transactions for Cargo Therapeutics, Inc. (CRGX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CARGO Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CARGO Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 19
2024
|
Gina Chapman President & CEO |
SELL
Open market or private sale
|
Direct |
2,975
-2.78%
|
$74,375
$25.03 P/Share
|
|
Sep 19
2024
|
Gina Chapman President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,975
+2.71%
|
$14,875
$5.03 P/Share
|
|
Sep 18
2024
|
Gina Chapman President & CEO |
SELL
Open market or private sale
|
Direct |
7,166
-6.45%
|
$179,150
$25.09 P/Share
|
|
Sep 18
2024
|
Gina Chapman President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,166
+6.06%
|
$35,830
$5.03 P/Share
|
|
Sep 18
2024
|
Anup Radhakrishnan Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,600
-19.89%
|
$40,000
$25.28 P/Share
|
|
Sep 18
2024
|
Anup Radhakrishnan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+16.59%
|
$8,000
$5.03 P/Share
|
|
May 30
2024
|
Samsara Bio Capital Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
294,000
+6.24%
|
$4,998,000
$17.0 P/Share
|
|
Jan 12
2024
|
Rtw Investments, LP > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
1,842,499
-26.25%
|
-
|
|
Nov 14
2023
|
Samsara Bio Capital Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
666,666
+13.92%
|
$9,999,990
$15.0 P/Share
|
|
Nov 14
2023
|
Samsara Bio Capital Gp, LLC |
BUY
Conversion of derivative security
|
Indirect |
3,381,323
+49.46%
|
-
|
|
Nov 14
2023
|
Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. |
BUY
Conversion of derivative security
|
Direct |
737,000
+50.0%
|
-
|
|
Nov 14
2023
|
Third Rock Ventures V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,333,333
+42.46%
|
$19,999,995
$15.0 P/Share
|
|
Nov 14
2023
|
Third Rock Ventures V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
473,786
+50.0%
|
-
|
|
Nov 14
2023
|
Third Rock Ventures V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
1,737,216
+50.0%
|
-
|
|
Nov 14
2023
|
Perceptive Advisors LLC |
BUY
Open market or private purchase
|
Indirect |
666,666
+30.13%
|
$9,999,990
$15.0 P/Share
|
|
Nov 14
2023
|
Perceptive Advisors LLC |
BUY
Conversion of derivative security
|
Indirect |
2,579,502
+50.0%
|
-
|